Epigenetic Risk Assesment of Assisted Reproductive Technologies
Assisted Reproduction Technologies (ART) are developing rapidly to provide response to infertility and to the cultural shift to postpone parenthood. Later childbearing and ART has been associated with an increased risk of the epig...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SARM
Endometrial and embryonic genomics searching for biomarkers...
3M€
Cerrado
SCME
Selecting Creating and Modifying Embryos the ethics of new...
195K€
Cerrado
EPIGEFXY
Epigenetic regulation of the sex chromosomes and male infert...
185K€
Cerrado
MACE
Maternal Communication with embryo
172K€
Cerrado
MATER
Innovative Training Network in Female Reproductive Care
4M€
Cerrado
SAF2008-01578
ESTABILIDAD EPIGENETICA EN GESTACIONES CONCEBIDAS POR TECNIC...
97K€
Cerrado
Información proyecto ERAofART
Duración del proyecto: 36 meses
Fecha Inicio: 2015-12-14
Fecha Fin: 2018-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Assisted Reproduction Technologies (ART) are developing rapidly to provide response to infertility and to the cultural shift to postpone parenthood. Later childbearing and ART has been associated with an increased risk of the epigenetic disorders in offspring. Thus, in order to guarantee better and safer healthcare for EU citizens, risks and benefits of the use of various ART procedures needs to be thoughtfully tested. The project aims at overcoming the existing gaps and strengthening our capacity in Epigenetic Risk Assessment of Assisted Reproduction Technologies (ERA of ART). Long term GOAL of our project is to become the European Centre of Excellence and Innovation for Epigenetic Risk Assessment of ART. To do this, we will create link between IGAB PAS, providing high quality know-how in mouse embryology with University of Wuerzburg (leader in epigenetic assessment of ART embryos), with University of Teramo (having long-standing expertise in wide range of ART procedures in large animals) and with Uniwersytet Jagiellonski (having long-standing expertise in human genetics). This twinning project will provide technological platform and expertise for epigenetic analyses and ART in large and small animal models. The specific aims of our project based on SWOT analysis are: 1) to enhance the scientific and technical skills of our staff; 2) stimulate preparation of joint research projects; 3) produce high impact factor publications and; 4) establish the cooperation with infertility clinics. The expected impact of this project is the creation of European Reference Network for ART safety evaluation, which is within the priorities of The Third Health Programme 2014-2020 of EC as well as within thematic area: HEALTHY SOCIETY of National Smart Specializations. This will have positive impact on the research in reproductive medicine and ART sector in general and will create a unique opportunity for Polish institution to become the reference Centre for knowledge-based decision making while preparing ART legislation.